We believe that the discrepancies in weight loss results between our study and the two studies using exenatide might be explained by the choice of drug
In people with both type 2 diabetes and obesity, an indirect comparison drawing on the separate SURMOUNT-2 (NCT04657003) and STEP 2 (NCT03552757) trials, rather than a single head-to-head study, reported weight reduction of up to 15.7% with tirzepatide and 10.6% with semaglutide 2.4 mg
Potential Side Effects and Risks of Lipotropic Injections (The Cons) As with any treatment or medication, its crucial to understand that lipotropic injections may have possible side effects and risks
Case # 1 The authors describe a case of an 82 year old, with a history of A
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS